Everwell Health, a dietary supplement, functional foods and beverages specialist and parent company of Nutrition21, has made two appointments to leadership roles.
 
Volkan Eren has assumed the newly-created role of vice president of sales and business development, while Catherine Kwik-Uribe, PhD, will serve as vice president of scientific and regulatory affairs.
 
Eren will head the sales team and lead commercial strategy and sales administration. Volkan has joined the company with a background in entrepreneurial businesses like Enzymotec along with increased responsibility leading sales teams at Frutarom and IFF. Eren will focus on business expansion and diversification, and lead the sales organization. Eren holds a bachelor’s degree in business administration and management from Farleigh Dickinson University and earned a master’s degree in economics from City University of New York.
 
Kwik-Uribe is responsible for maintaining the reputation of Nutrition21, Everwell Health’s first platform investment, while creating new strategies to build expertise, ideas, and processes that support the company’s science-first approach. Kwik-Uribe most previously worked at Mars Incorporated, and her most recent role was vice president of scientific and regulatory affairs, applied science and nutrition, for Mars Edge. Kwik-Uribe has worked across multiple product categories and has led scientific teams of various sizes, and has conducted research in human health and nutrition leading to the translation of science into consumer-relevant claims. She will drive the company’s clinical research needs and support new product claims and regulatory approvals in the U.S. and international markets. Kwik-Uribe earned her PhD in human nutrition from University of California, Santa Cruz, and has authored and co-authored more than 40 publications on the analysis, safety, and efficacy of nutrients and bioactive constituents in foods.
 
Both executives bring mergers and acquisitions experience that will be important as Everwell Health invests to expand its reach.
 
“These new leaders compliment our existing team at Nutrition21,” said Steve Rosenman, CEO of Everwell Health. “Their experience and success, both at nimble, high-growth companies and at highly professional, scaled global enterprises will support Everwell Health’s dual growth strategy of optimizing organic opportunities at Nutrition21, while aggressively developing strategic partnerships and pursuing external business development. These roles align with our commitments and continued investments in science, and in capabilities to serve our customers and help them grow.”